SEB Asset Management AB »

Cogent Biosciences shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.3M 164k 38.49

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Rtw Investments
Vanguard Portfolio Management
Vanguard Capital Management
Henderson Group
Fairmount Funds Management
TCG Crossover Management
State Street Corporation
Goldman Sachs Group
Kynam Capital Management
Geode Capital Management
Lord, Abbett & Co

View all funds holding Cogent Biosciences